Professor of Medicine, University Mich Medical School
Internal Medicine
Dr. Marc E. Lippman, MD
|
|
Give Review
Dr. Marc E. Lippman is an expert in the field of Internal Medicine. He graduated from Yale University School of Medicine. Yale University School of Medicine is a top medical university. Yale University School of Medicine is ranked 7/57 in Research/PrimaryCare. He received 7 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Top Doctors:South Florida", "CMS Meaningful Use Stage 1 Certification", "Redbook Magazine: Top Breast Cancer Doctors", "Super Doctor" and "Whos Who in Medicine and Healthcare". Marc Lippman is a published MD. He published 23 publications, including: 'Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer.' Doctor Marc E. Lippman, MD is registered with Medicare and accepts Medicare payments.
Publications
- Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer.
- Loss of the E3 ubiquitin ligase HACE1 results in enhanced Rac1 signaling contributing to breast Cancer progression.
- Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast Cancer and predict poor clinical outcome.
- Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and Cancer-associated fibroblasts in dissociated tumor (DT) cultures.
- Paget's Disease of the nipple.
- Mechanisms of estrogen-independent breast Cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivation.
- Rescue of tropomyosin deficiency in Drosophila and human Cancer cells by synaptopodin reveals a role of tropomyosin ? in RhoA stabilization.
- Twenty-five year results of the national Cancer institute randomized breast conservation trial.
- Erratum to: Editorial: Cost-effective analyses in Breast Cancer Research and Treatment.
- An expression signature of estrogen-regulated genes predicts Disease-free survival in tamoxifen-treated patients better than progesterone receptor status.
- Effect of raloxifene on the incidence of invasive breast Cancer in postmenopausal women with osteoporosis categorized by breast Cancer risk.
- GREB1 is a novel androgen-regulated gene required for prostate Cancer growth.
- (-)-Gossypol enhances response to radiation therapy and results in tumor regression of human prostate Cancer.
- Long-term follow-up for locally advanced and inflammatory breast Cancer patients treated with multimodality therapy.
- Discovery of embelin as a Cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine thr...
- Pro-matrix metalloproteinase-2 transfection increases orthotopic primary growth and experimental metastasis of MDA-MB-231 human breast Cancer cells in nude mice.
- Targeting Bcl-2 and Bcl-XL With nonpeptidic small-molecule antagonists.
- Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.
- Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis.
- Dietary modulation of pregnancy estrogen levels and breast Cancer risk among female rat offspring.
- Development and validation of a method for using Breast core needle biopsies for gene expression microarray analyses.
- Mobilization of peripheral blood stem cells with paclitaxel and rhG-CSF in high-risk breast Cancer patients.
Schools
Yale University
Johns Hopkins Hospital
National Canc Institute
Yale
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anemia
- Basal Cell Carcinoma
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Internal Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- AvMed
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Employer Group Open Access HMO
- Employer Group PPO
- Golden Rule
- Choice Care PPO
- Preferred PPO
- Select HMO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Neighborhood Health Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Neighborhood Health Partnership
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Top Doctors:South Florida
- CMS Meaningful Use Stage 1 Certification
- Redbook Magazine: Top Breast Cancer Doctors
- Super Doctor
- Whos Who in Medicine and Healthcare
Education
-
Johns Hopkins University -
Yale University School of Medicine
Hospital
-
University of Miami Hospital -
Miami Veterans Affairs Healthcare System
Drug Facts
| NPI NUMBER | 1578649430 | |
| NPPES Provider LastName | LIPPMAN | |
| NPPES Provider FirstName | MARC | |
| NPPES Provider ZIPCode | 331361002 | |
| NPPES Provider State | FL | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 127.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1578649430 |
| Last Name Of The Provider | LIPPMAN |
| First Name Of The Provider | MARC |
| View All |
Similar Doctors
|
|
Dr. Lester F. Shalloway, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan D. Lin, MD |
|
|
Dr. Merideth S. Davis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Lipp, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine F. Welsh, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Myriam Landrin, MD
This Doctor is OpenDoctor Recommended.
|